Aptuit Initiates Growth Program

To invest $16 million in discovery and CMC capacity and capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Aptuit LLC has initiated a growth program for 2016 to increase discovery, Chemistry, Manufacturing and Controls (CMC), and non-clinical development capabilities. Aptuit will hire an additional 90 scientists at its facilities in Oxford, UK and Verona, Italy and will invest $16 million in facility upgrades and equipment to enhance development capabilities.   For its Drug Design & Discovery services, additional capacity and targeted investments will be made in hit identification solutions, tr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters